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INTERLEUKIN-1-INDUCED COX-2 AND INOS EXPRESSION IN OA HUMAN
CHONDROCYTES IS ASSOCIATEDWITH HISTONE H3K4 METHYLATION
F. El Mansouri, N. Chabane, N. Zayed, J. Martel-Pelletier, J.-P. Pelletier,
h. Fahmi
Montreal Univ., Montreal, QC, Canada
Purpose: Increased expression of inducible NO synthase (iNOS) and cy-
clooxygenase (COX)-2 plays a key role in the pathogenesis of osteoarthritis
(OA). Methylation of lysine 4 on histone H3 (H3K4) was shown to be of fun-
damental importance in the regulation of gene expression. In the present
study, we investigated the role of H3K4 methylation in interleukin-1β
(IL-1)-induced COX-2 and iNOS expression in human OA chondrocytes
Methods: Chondrocytes were stimulated with IL-1 for various time periods
and the expression of iNOS and COX-2 mRNAs and proteins were evaluated
using real-time reverse transcriptase-polymerase chain reaction (RT-PCR)
and Western blotting, respectively. H3K4 methylation at the iNOS and
COX-2 promoters was evaluated using chromatin immunoprecipitation
(ChIP) assays. The role of histone methylation was further evaluated using
the methyltransferase inhibitor, 5’-deoxy-5’(methylthio) adenosine (MTA).
Results: IL-1 induced iNOS and COX-2 mRNA and protein in a dose- and
time-dependent manner. The induction of iNOS and COX-2 expression by
IL-1 was associated with H3K4 di- and trimethylation at the iNOS and
COX-2 promoters, whereas the levels of H3K4 monomethylation remained
unchanged. Treatment with MTA inhibited IL-1-induced H3K4 methylation
as well as IL-1-induced iNOS and COX-2 expression.
Conclusions: These results indicate that H3K4 methylation contributes
to IL-1-induced iNOS and COX-2 expression and suggest that this path-
way could be a potential target for pharmacological intervention in the
treatment of OA.
200
SULFORAPHANE REPRESSES MATRIX-DEGRADING PROTEASES AND
PROTECTS CARTILAGE FROM DESTRUCTION IN VITRO
R.K. Davidson1, K.L. Culley1, R. Norton1, M. O’Connell1, A. Cooper2,
S.T. Donell2, Y. Bao1, I.M. Clark1
1Univ. of East Anglia, Norwich, United Kingdom; 2Norfolk and Norwich Univ.
Hosp., Norwich, United Kingdom
Purpose: Sulforaphane (SFN) is a naturally occurring isothiocyanate found
at high levels in cruciferous vegetables (particularly broccoli) and is part of
the habitual human diet. SFN is reported to be a histone deacetylase (HDAC)
inhibitor and we and others have described classical HDAC inhibitors as
chondroprotective. Further, SFN has also been shown to function via ac-
tivation of the Nrf2 transcription factor. Hence, we investigated SFN as a
chondroprotective agent whilst examining HDAC inhibition and induction
of the Nrf2 transcription factor as two potential mechanisms of action in
chondrocytes.
Methods: Primary human articular chondrocytes (HACs) and the SW1353
chondrosarcoma cell line were grown in monolayer culture and treated
with interleukin-1 (IL-1) and oncostatin M (OSM) in the presence or ab-
sence of SFN. Histone deacetylase activity was detected by western blotting
for histone acetylation. Inhibition of cytokine-induced metalloproteinase
expression was measured using quantitative RT-PCR and western blot-
ting. Bovine nasal cartilage and human articular cartilage explant models
were used to measure cartilage destruction. siRNA knockdown was used
to examine the function of Nrf2 in the regulation of metalloproteinase
expression in chondrocytes.
Results: SFN at 2.5-30 μM did not affect histone H3 or H4 acetylation in
primary HACs or the SW1353 cell line. SFN at 2.5-10 μM dose-dependently
attenuated cytokine-induced MMP1, MMP3, MMP13 expression in HACs
and SW1353 cell line. ADAMTS5 and ADAMTS4 cytokine-induced expression
was repressed by the same SFN treatment in HACs. Cytokine-induced
cartilage destruction in vitro was abrogated by SFN in both bovine and
human cartilage explant models. The Nrf2 pathway was active in chondro-
cytes, and activated by SFN treatment, but did not mediate repression of
metalloproteinase expression by SFN.
Conclusions: SFN can dose-dependently attenuate the induction of metal-
loproteinase expression and protect against cartilage destruction in vitro.
These actions are not mediated by the inhibition of histone deacetylases
or the induction of the Nrf2 transcription factor. SFN is a potential
chondroprotective agent.
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CCAAT ENHANCER BINDING PROTEIN MEDIATES CATABOLIC PROCESSES
OF ARTHRITIS CARTILAGE
K. Okazaki, H. Tsushima, M. Hayashida, Y. Iwamoto
Kyushu Univ., Fukuoka, Japan
Purpose: Matrix metalloproteinases (MMPs) are considered to be major
proteases which degrade cartilage matrix structures in osteoarthritis (OA)
cartilage. The expressions of MMPs are regulated by many factors such
as mechanical stresses, oxidants, matrix fragments, phenotypic change of
chondrocytes and inﬂammation. CCAAT/enhancer-binding protein (C/EBP)
is a family of basic leusine zipper transcriptional factors which mediates
many inﬂammatory signals. In fact, C/EBPβ is expressed in tissues of OA as
well as rheumatoid arthritis (RA). The purpose of this study is to investigate
the involvement of C/EBP in the expression of catabolic enzymes in arthritis
cartilage.
Methods: Immunohistochemistry: To examine the expression pattern of
C/EBPβ and MMP-3 and 13 in OA cartilage, immunohistochemical staining
was performed in the articular cartilage obtained from patients with OA at
the time of total knee arthroplasty.
Cell culture: C-28/I2 immortalized human chondrocytes and SW982 human
synovial sarcoma cells were cultured.
Gene overexpression: Transient transfection was performed to cell lines
using adenovirus expression vectors for C/EBPβ
Gene knockdown: C/EBPβ Silencer Pre-designed siRNA.
Promoter assay: We constructed the pGL4-basic vector containing the 5’-
ﬂanking region of the human MMP-3 and MMP-13 promoter. Promoter
constructs and an C/EBPβ-LAP expression vector were cotransfected into
C-28/I2.
ChromatinImmunoprecipitation (ChIP) Assay: The C-28/I2 cells were treated
with TNF-α (2ng/ml). For immunoprecipitation, anti-C/EBPβ antibody or
normal rabbit IgG was used.
Results: Immunohistochemistry showed that C/EBPβ, MMP-3 and -13 were
co-expressed in the degenerative cartilage. Western blot analysis revealed
the expression of C/EBPβ in both cell lines after treatment with IL-1β. In
cells transfected with adenovirus expression vector for C/EBPβ, MMP-1, -3,
13 and ADAMTS-5 expression were signiﬁcantly increased (Fig. 1). C/EBPβ
knockdown with SiRNA dramatically reduced the MMP-3 expression in
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C-28/I2 and SW982, and reduced MMP-13 expression in C-28/I2 (Fig. 2).
Promoter assay was showed that C/EBPβ stimulates the promoter activities
of MMP-3 and -13 in a dose-dependent manner (Fig. 3). Deletion analysis
revealed the C/EBPβ responsive elements in the promoter of MMP-3 and
-13. ChIP assay was performed using primers constructed from the human
MMP-3, -13 and ADAMTS-5 promoter sequences which amplify the sites
included the C/EBPβ consensus binding motifs. This analysis indicated that
C/EBPβ binds to these promoter regions.
Conclusions: C/EBPβ mediates multiple factors in arthritis. For example,
C/EBPβ activates factors of inﬂammation, such as phospholipase A2 and
cyclooxygenase-2. C/EBPβ also mediates the repression of cartilage derived-
retinoic acid sensitive protein (CD-RAP) in response to IL-1β. It is also
reported that C/EBPβ mediates the expression of MMP-1. Furthermore, it
is reported that C/EBPβ mediates signals for the hypertrophic change of
chondrocyte in OA cartilage. In this study we showed that C/EBPβ is also
involved in the expression of MMP-3, 13 and ADAMTS-5 in synovium and
cartilage of arthritis. These results suggest that C/EBPβ plays important
roles in the catabolic processes in arthritis cartilage.
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DIFFERENTIAL ROLES OF CYCLOOXYGENASE 1 AND 2 DURING
CHONDROGENESIS
M.J. Caron1, T.J. Welting1, M.M. Coolsen1, P.J. Emans1, D.A. Surtel1,
A. Cremers1, J.-W. Voncken2, L.W. van Rhijn1
1Maastricht Univ. Med. Ctr., Dept. Orthopaedic Surgery, Maastricht,
Netherlands; 2Maastricht Univ. Med. Ctr., Dept. Molecular Genetics,
Maastricht, Netherlands
Purpose: In cartilage regenerative techniques, inferior collagen content
of cartilage constructs is a major complicating factor. COX-2 is essential
during fracture healing as knockout of COX-2 impairs fracture healing.
Furthermore, mesenchymal progenitor cells and the developing growth
plate show COX-1 and COX-2 expression, indicating a role for COX- en-
zymes during endochondral ossiﬁcation. However, it is poorly understood
how COX-1 and COX-2 are regulated during chondrogenesis and by which
molecular mechanisms they inﬂuence chondrogenic differentiation and
collagen synthesis. We hypothesize that chondrogenesis can be modulated
by manipulation of COX activity.
Methods: The chondrogenic progenitor cell line ATDC5 and dedifferenti-
ated primary human articular chondrocytes (HACs) were (re)differentiated.
COX-activity was inhibited by increasing concentrations of COX-1 and COX-
2 non-speciﬁc and speciﬁc inhibitors (NSAIDs: indomethacin, mofezolac
and NS398, respectively) added from different time points in differentia-
tion. Protein and mRNA expression of Col2A1, Col10A1 and COX-1/2 was
analyzed at day 14 (ATDC5) or day 7 (primary chondrocytes) in cell lysates
by RT-qPCR and immunoblot analysis.
Results: Addition of the non-speciﬁc NSAID indomethacin from the start
of ATDC5 differentiation heavily affected Col2A1 and Col10A1 expression.
In contrast, redifferentiation of primary human chondrocytes was not
affected when a similar indomethacin concentration (20 μM) was used.
Surprisingly, Col2A1 and Col10A1 synthesis was enhanced in the latter
cultures. This seemingly paradoxal effect might be explained by differential
roles of COX-1 and COX-2 during different chondrogenic phases. Indeed,
addition of indomethacin during ATDC5 differentiation from day 8 (when
ATDC5 adopts chondrocyte characteristics) resulted in a similar increased
Col2A1 and Col10A1 expression as in redifferentiation of primary HACs
with indomethacin. To elucidate the role of the individual COX-enzymes
during different chondrogenic phases, speciﬁc COX-1 and COX-2 inhibitors
were added to ATDC5 cells from the start or from day 8 in differentiation.
When added from day 0, mofezolac (COX-1 speciﬁc) dose-dependently
decreased Col10A1 synthesis similar to indomethacin, but increased Col2A1
synthesis. When added from day 8, mofezolac showed an overall decreased
collagen synthesis. In contrast, NS398 (COX-2 speciﬁc) speciﬁcally inhibited
Col10A1 and did not inﬂuence Col2A1 expression when added from the
start of ATDC5 differentiation. Addition of NS398 from day 8 in ATDC5
differentiation resulted in increased Col2A1 expression and only slightly
increased Col10A1 expression.
Conclusions: Our ﬁndings point to a differential and differentiation phase
dependent role for COX-enzymes during chondrogenesis. Our preliminary
data show that the expression levels of COX-1 and COX-2 depend on the
chondrocyte differentiation phase, thereby partly explaining differential
effects of NSAIDs during different chondrogenic phases. Ongoing research
focuses on further elucidating the functional partition of COX-enzymes
and prostaglandins during chondrogenesis for improving the outcome of
cartilage regenerative techniques.
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CXCR1 AND CXCR2 SIGNALLING IS REQUIRED BUT IS NOT SUFFICIENT TO
MAINTAIN THE PHENOTYPIC STABILITY OF HUMAN ARTICULAR
CHONDROCYTES
J. Sherwood, S. Key, P. Achan, G. Nalesso, C. Pitzalis, F. Dell’Accio
Barts and The London Sch. of Med. and Dentistry, Queen Mary Univ. of
London, London, United Kingdom
Purpose: Articular chondrocytes are not known to migrate in vivo, yet
they express chemokine receptors. The function of ELR+ CXC chemokine
receptors in these cells is therefore unknown. In addition to the receptors,
chondrocytes also express their ligands thereby suggesting a paracrine-
autocrine signalling mechanism. In this study we have hypothesised that
ELR+ CXC chemokine signalling via the receptors CXCR1 and CXCR2
in chondrocytes has a physiological role in cartilage homeostasis and
particularly in the maintenance of the chondrocytic phenotype.
Methods: Adult human articular chondrocytes (AHAC) were isolated by
enzymatic release from preserved areas of the femoral condyles of patients
undergoing joint replacement for osteoarthritis. Chondrocytes were ex-
panded in monolayer culture under standard conditions. Gene expression
analysis was performed by real time quantitative PCR and at protein level,
the expression of CXCR1 and CXCR2 was conﬁrmed using Western blot and
immunoﬂuorescence. CXCR-1/-2 functionality was tested using a calcium
inﬂux assay. CXCR-1/-2 signalling was either blocked at the Gαi level using
pertussis toxin or at the receptor level using blocking antibodies. The
expression of molecular markers associated with the stable cartilage phe-
notype was assessed using real time PCR. The content of highly sulphated
proteoglycans in chondrocyte micromasses was analysed using Alcian blue
staining at pH0.2 followed by guanidine extraction and spectrophotometric
quantiﬁcation.
Results: Early passage articular chondrocytes expressed CXCL1, CXCL8 and
CXCL6 as well as their receptors CXCR1 and CXCR2. CXCR1 and CXCR2 ex-
pression was conﬁrmed at protein level by Western blotting, and receptor
functionality was shown by an increase in calcium inﬂux following ligand
stimulation. Confocal microscopy conﬁrmed the localisation of both recep-
tors at the cell membrane as well as within the cytoplasm, as expected for
the well known internalisation and recycling of these receptors and for the
autocrine/paracrine production of their ligands. The expression of both the
ligands and receptors was conﬁrmed at mRNA and protein level in freshly
dissected cartilage biopsies. Blocking CXCR1/2 signalling at both G protein
and at receptor level in early passage AHAC resulted in a downregulation
of type II collagen, aggrecan and SOX9 mRNA. In addition, CXCR blockade
in chondrocyte micromasses resulted in a net decrease of highly sulphated
glycosaminoglycan content as evaluated by Alcian blue staining. However,
supplementation of CXCR1 and CXCR2 ligands during cell expansion did
not lead to an enhanced cartilage phenotype or to the maintenance of
phenotypic molecular markers at gene expression level.
Conclusions: CXCR1 and CXCR2 are expressed and are functional in adult
human cartilage and cultured articular chondrocytes.
CXCR1 and CXCR2 blockade results in the downregulation of some but not
all molecular markers associated with the capacity of AHAC to form stable
cartilage in vivo.
CXCR signalling is required for the phenotypic stability of articular chon-
drocytes in vitro and therefore may play a role in cartilage homeostasis in
vivo.
CXCR1 and CXCR2 supplementation is not suﬃcient to maintain the
phenotypic stability of articular chondrocytes during in vitro expansion.
